PNPLA2 Antikörper (AA 30-504)
Kurzübersicht für PNPLA2 Antikörper (AA 30-504) (ABIN5776211)
Target
Alle PNPLA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 30-504
-
Verwendungszweck
- Human PEDFR/PNPLA2 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human ATGL (30-504aa) purified from E. coli
-
Isotyp
- IgG2b kappa
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- PNPLA2 (Patatin-Like phospholipase Domain Containing 2 (PNPLA2))
-
Andere Bezeichnung
- PEDFR/PNPLA2
-
Hintergrund
- Adipose triglyceride lipase (ATGL) is a 504 amino acid protein that is highly expressed in mouse and human adipose tissue. ATGL is catalyzes the initial step in triglyceride hydrolysis in adipocyte lipid droplets and has acylglycerol transacylase activity. Inhibition of ATGL markedly decreases total adipose acyl-hydrolase activity. Thus, ATGL and hormone-sensitive lipase coordinately catabolize stored triglycerides in adipose tissue of mammals.
-
NCBI Accession
- NP_065109
Target
-